$180 million in medical research to improve the lives of Australians

The Morrison Government is investing $180 million in ground-breaking medical research projects around Australia to improve the lives of Australians and their loved ones.
Funded through the Government’s $20 billion Medical Research Future Fund, 106 medical research projects will receive funding to improve health outcomes, including for Australians with cancer, dementia, brain injuries, heart problems, neurofibromatosis and many others.
$18.7 million will be provided through the Stem Cell Mission for 17 projects that will address illnesses facing many Australians and their families, including heart disease, COVID-19, epilepsy and childhood cancer.
The Murdoch Children’s Institute will receive almost $1 million to evaluate the potential of a bioengineered heart tissue to be used for congenital heart repair in children. This project will radically transform patient outcomes and improve the quality of life of children affected by heart disease.
Through the Genomics Health Futures Mission, 17 researchers will receive a share of $46.5 million for genomics research, which will support health clinicians to identify genetic disorders and diagnose rare diseases faster, positioning Australia as a global leader in this area.
Australian researchers fighting against paediatric and childhood cancers will also receive $18.4 million as part of the 2020 Paediatric Cancer Grant Opportunity and 2020 Childhood Cancer Research Grant Opportunity, to improve treatment, therapies and survival rates for Australian kids.
To improve health outcomes for Australian patients, we’re investing $12.9 million in seven research projects that will use data to improve access, quality, safety and efficiency of our primary health care system as part of the 2020 Primary Healthcare Research Data Infrastructure grants.
Monash University will receive $9.6 million to focus on discovery research projects, including next-generation precision oncology, tumour immunotherapy and epigenomics, which will help make a real world difference for the thousands of Australian kids each year facing a cancer diagnosis and the fight of their lives.
Cancer remains the leading cause of death in Australia. We’re providing $21 million through the 2020 Improving Diagnosis in Cancers with Low Survival Rates Grant Opportunity to eight projects, which aim to improve the early diagnosis of ovarian cancer, liver cancer, lung cancer, as well as cancers where the primary site or origin is unknown.
We are supporting home grown research into cardiovascular health, with $20.1 million in new funding to support 16 projects from real-time cardiac monitoring, to after stroke care for Aboriginal and Torres Strait Islander patients, from medicine management for stroke patients to arm strength and rehabilitation.
We’re providing $17 million for 11 research projects as part of the Dementia, Ageing and Aged Care Mission, which will help senior Australians maintain their health and quality of life as they age, keep their independence for longer and access quality care when they need it.
Seven projects will receive a share of $7.4 million to improve the health of Aboriginal and Torres Strait Islander people through the 2020 Indigenous Health Research Grant Opportunity.
Australian researchers at the University of Melbourne are investigating further COVID-19 vaccine candidates. Through the COVID-19 Vaccine Candidate Research grants, we’re providing $6 million to the University for two projects to help protect Australians against future pandemics.
The 2020 International Clinical Trial Collaborations grant opportunity is providing $5.6 million for three projects, which will bring international clinical trials into back pain, caesarean births and Hodgkin lymphoma.to Australia.
$4.6 million will also be provided through the 2020 Neurofibromatosis Research grant opportunity to four Australian research projects looking into neurofibromatosis – a devastating genetic condition that can cause cancer, blindness, deafness, and chronic pain.
To help improve the lives of Australians who have suffered a traumatic brain injury (TBI), we’re providing $3.3 million to six projects through the Traumatic Brain Injury Mission.
These grants are part of the Morrison Government’s $20 billion Medical Research Future, which is a long-term, sustainable investment in Australian health and medical research helping to improve lives, build the economy and contribute to the sustainability of the health system.
Further information about the MRFF is available at www.health.gov.au/mrff

2020 Genomics Health Futures Mission Grant Opportunity

Institution Project Funding
Murdoch Children’s Research Institute The Australian Functional Genomics Network $6 million
Murdoch Children’s Research Institute A national large-scale automated reanalysis program to increase rare disease diagnosis $3 million
Murdoch Children’s Research Institute New technologies for improved diagnosis of ataxia and the repeat expansion disorders $653,000
Murdoch Children’s Research Institute Mitochondrial Diagnostic Network for Genomics and Omics $3 million
Murdoch Children’s Research Institute The Australian Undiagnosed Diseases Network (UDN-Aus): An internationally networked national approach for transforming diagnosis for individuals living with rare diseases $3 million
James Cook University The KidGen National Kidney Genomics Program – improving genomic outcomes for Australian families with genetic kidney disease $3 million
University of Western Australia Closing the gap in diagnosis of neurological disorders including ataxias and neuropathies – a trans-Australia collaboration $3 million
University of Melbourne Genetic mosaicism as a stable and robust blood DNA biomarker for precision risk assessment for cancer $2.1 million
University of Melbourne Precision Diagnosis for the Remaining 50% of Unsolved Developmental and Epileptic Encephalopathies $3 million
University of Melbourne Diagnosis, discovery and novel phenotype characterisation using multimodal genomics in patients with inherited bone marrow failure and related disorders $3 million
University of Melbourne Evaluating clinically relevant biomarkers to improve early detection and treatment of head and neck cancer $2.2 million
University of Melbourne Novel predictive disease modelling using liquid biopsies to improve outcomes in melanoma $2 million
University of Sydney Genomic risk prediction and risk-tailored screening and early detection for common cancers $3 million
Monash University Population genomic screening of young adults to prevent cancer in Australia $3 million
University of Queensland Improving genomic testing rates for inoperable lung cancer patients $2.5 million
Flinders University A liquid biopsy DNA methylation blood test for personalised treatment of patients with gastrointestinal cancers $2 million
Macquarie University Integrated Multimodal Precision Liquid biopsy to Enhance MElanoma and NSCLC Treatment (IMPLEMENT) $2 million

2020 Stem Cell Therapies Mission Grant Opportunity

Institution Project Funding
Murdoch Children’s Research Institute Evaluating safety and efficacy of bioengineered heart tissue for congenital heart repair $999,000
Murdoch Children’s Research Institute New therapies preventing heart damage during chemotherapy $879,000
Murdoch Children’s Research Institute Stem cell models of glomerular kidney disease for understanding disease and developing treatments $934,000
Murdoch Children’s Research Institute  
Insights into CDKL5 neuronal regulation: pathways to improving neurological outcomes for CDKL5 Deficiency Disorder
$854,000
University of Melbourne Stem cell therapies for digestive disease $584,000
University of Melbourne iPSC clinical trials – population wide screening of patient iPSC’s to reassess high value drug targets for motor neuron disease $1 million
University of Sydney Induced pluripotent stem cell derived cardiomyocytes: a new therapy for “no-option” end stage heart failure
 
$5 million
University of Sydney Stem Cell Derived-Retinal Organoids to Test Novel Genetic Therapies $498,000
University of Sydney  
Improving decisions about access to stem cell interventions
 
$800,000
Monash University Locally administered extracellular vesicles for perianal fistulising Crohn’s disease $936,000
The University of Adelaide A Precision Medicine Based Approach to Treat Craniosynostosis in Children $441,000
The University of Adelaide Developing an Evidence-Based Model for Building Trust in Australian Stem Cell Research and Therapies $995,000
University of Wollongong Novel SMART AAV vectors for gene therapy for Friedreich’s Ataxia $983,000
The University of Queensland Transforming the paradigm of epilepsy care with precision medicine $1 million
University of South Australia Identification and assessment of new treatment options for the childhood cancer Neuroblastoma $982,000
South Australian Health and Medical Research Institute Limited Engineered human stem cells for mutation-specific eradication of myelofibrosis $853,000
The Commonwealth Scientific and Industrial Research Organisation (CSIRO) the sySTEMs initiative: systems biology-augmented, stem cell-derived, multi-tissue panel for rapid screening of approved drugs as potential COVID-19 treatments $998,000

2020 Paediatric Cancer Grant Opportunity

Institution Project Funding
Monash University The Victoria Paediatric Cancer Consortium: A multi-institutional partnership to catalyze advances in childhood cancer research and clinical implementation $9.6 million

2020 Childhood Cancer Research Grant Opportunity

Institution Project Funding
University of New South Wales Improving outcomes for children with high risk cancer $1.5 million
University of New South Wales Rationalised inclusion of HDAC inhibitors with standard-of-care chemotherapy to improve outcomes for primary and relapsed neuroblastoma $614,000
University of Melbourne Studying the origins, maintenance and resistance mechanisms of poor prognosis paediatric leukaemia at single cell resolution to develop novel therapeutic approaches. $1.5 million
University of Sydney Alternative Lengthening of Telomeres (ALT): Target discovery to treatment $1.48 million
The University of Adelaide Adolescents with Acute Lymphoblastic Leukaemia: Focussing on the gut microbiota, its role in therapeutic response and potential as an effective adjunct therapeutic in this high-risk group $1.29 million
University of South Australia ABOLISH Neuroblastoma: Defining the Aetiology and underlying BiOLogy of neuroblastoma to Innovate and SHape new options for prevention, diagnosis and treatment $1.42 million
St Vincent’s Institute of Medical Research Reducing tumour incidence in adolescents with germ-line mutations in RECQL4 $958,000

2020 Primary Healthcare Research Data Infrastructure Grant Opportunity

Institution Project Funding
The University of Queensland Improving surveillance infrastructure for Indigenous primary health care  $2 million
South Australian Health and Medical Research Institute Limited Registry of Senior Australians: Improving Care and Outcomes in Aged Care $2 million
University of Melbourne Platform to Enhance Prostate Cancer Shared care Integration (PEPSI)
 
$2 million
Monash University
 
Optimising health information exchange during aged care transfers   $2 million
The University of Adelaide Imagendo: Diagnosing endometriosis with imaging and AI $2 million
Kimberley Aboriginal Medical Services Limited Regional collaboration to create a Kimberley Health Evidence Data Platform.  $1 million
Menzies School of Health Research Territory Integrated Care: Primary health data Linkage Using Software $2 million

2020 Improving Diagnosis in Cancers with Low Survival Rates Grant Opportunity

Institution Project Funding
University of New South Wales
 
Microbial based biomarkers powered by artificial intelligence for early detection of liver cancer in Australia. The Australian Liver Cancer Microbiome Consortium $4 million
University of South Australia
 
Predicting and Preventing Ovarian Cancer: a machine learning approach $1.3 million
The University of Queensland
 
Implementing a Multivariate Index Assay for the Earlier Detection of Ovarian Cancer $2.7 million
The University of Queensland
 
Lung cancer screening for early detection $2.8 million
University of Sydney
 
Ready to screen. Targeting the high-risk population to improve lung cancer diagnosis $2 million
University of Western Australia
 
The IC3 Trial: Identifying Cirrhosis and Liver Cancer in Primary Care $3.2 million
Swinburne University of Technology
 
Solving Unknown Primary cancER Earlier Diagnosis (SUPER-ED): A stepped wedge cluster randomised controlled trial implementing a new model of care to support earlier diagnosis $2.4 million
Flinders University
 
Shining Light into the “unknown” on Indigenous and non-Indigenous Australians with Cancer of Unknown Primary $2.4 million

2020 Cardiovascular Health Grant Opportunity

Institution Project Funding
Monash University Statins and Progression of Coronary Atherosclerosis in Melanoma Patients Treated with Immune Checkpoint Inhibitors $1.7 million
Monash University ECMO-Rehab: A Randomised Controlled Trial of Early Cardiac Rehabilitation to Improve Survival and Recovery in Critically-ill Patients on ECMO $663,000
Monash University New models of rehabilitation to improve work and health outcomes after stroke $1 million
The University of Newcastle Stroke in patients with large Ischaemic Core: Assessment of Reperfusion therapy Impact on Outcome (SICARIO) $1.5 million
The University of Newcastle Yarning up After Stroke $485,000
University of Sydney Safety and Tolerability of AZD6482 in Reperfusion for Stroke (STARS) $2.7 million
University of Sydney LesioLogic $1.1 million
University of Sydney Digital solutions for heart failure best practice care $937,000
University of Sydney Guardian Angel: Implementation of a peer support program for people with heart disease $656,000
University of Melbourne REACHING FOR YOUR WORDS: A Phase IIa umbrella trial of integrated UPper limb & Language Impairment and Functional Training (UPLIFT) after stroke. $993,000
University of Melbourne Improving life after stroke with tailored support: Innovation in use of national registry data $506,000
The University of Adelaide The SPRINTS Project: Stroke – Prevention of Reperfusion Injury and Neuroinflammation – a Therapeutic Strategy $2.6 million
University of New South Wales Development of novel, clinically viable strategies for reducing cardiac damage and preventing future events in myocardial infarction (MI) survivors by targeting inflammation $2.8 million
University of New South Wales CardiacAI: Deep learning to predict and prevent secondary cardiovascular events $545,000
The University of Queensland Measuring, Monitoring, and Motivating Adherence to Self-Managed Aphasia Treatment $389,000
The University of Queensland Development of drugs to prevent ischemic injuries of the heart and brain $1,499,560

2020 Dementia, Ageing and Aged Care Grant Opportunity

Institution Project Funding
The University of Queensland Alignment, Harmonisation, and Results: translating Core Outcome Measures to Improve Care (COM-IC) for People Living with Dementia into Australian practice $999,000
The University of Queensland Technology Assisted and Remotely Delivered Anxiety Psychotherapy Intervention for People living with Dementia and Their Care Partners (Tech-CBT) $1.6 million
National Ageing Research Institute Drawing out care: Using animation and digital technologies to support Culturally and Linguistically Diverse (CALD) family carers and people living with dementia $798,000
Monash University Knowledge brokers for evidence translation to improve quality use of medicines in residential aged care $2 million
Macquarie University
 
SENSEcog aged care: Hearing and vision support to improve quality of life for people living with dementia in residential aged care $1.2 million
Flinders University Creating partnership in iSupport program to optimise carers’ impact on dementia care $1.4 million
University of New South Wales Development, validation and implementation of a computerised tool to assess instrumental activities of daily living $1.3 million
Florey Institute of Neuroscience and Mental Health Blood testing to predict and discriminate dementias $4 million
University of Melbourne Music Attuned Technology Care eHealth (MATCH): A music based mobile eHealth $2 million
University of Melbourne Development and Implementation of the National Infection Surveillance Program for Aged Care (NISPAC) $998,000
University of Melbourne IMpleMenting Effective infection prevention and control in ReSidential aged carE (IMMERSE) $758,000

Indigenous Health Research Fund – 2020 Indigenous Health Research

Institution Project Funding
The University of Adelaide Working with Aboriginal families and health and social service providers to assess the feasibility of a novel care package to reduce cannabis and alcohol use and social stress in pregnancy $675,000
The Council of the Queensland Institute of Medical Research Developing cultural sensitivity and capability through communication training for mental health professionals $705,000
University of New South Wales Understanding how cultural resilience impacts Aboriginal health & quality of life $560,000
University of Sydney Understanding the contribution of Aboriginal and Torres Strait Islander culture and wellbeing to health: Implementation of the What Matters 2 Adults wellbeing measure
 
$998,000
La Trobe University Healing the Past by Nurturing the Future: Trauma-integrated perinatal care to improve health outcomes for Indigenous parents and infants in a rural setting $1.5 million
University of Sydney VOICE – Validating Outcomes by Including Consumer Experience. Developing a patient reported experience measure for Aboriginal and Torres Strait Islander people accessing primary health care $1.4 million
The Sax University Indigenous Led Evaluation of Aboriginal Programs (ILEAP) $1.5 million
 

2020 COVID-19 Vaccine Candidate Research Grant Opportunity – Round 3

Institution Project Funding
University of Melbourne AdaptiVax-CoV: A novel adaptable SARS-CoV2 VLP vaccine to produce broad humoral and T cell responses to S, E and M viral proteins $3 million
University of Melbourne Chimeric next generation COVID vaccines $3 million

2020 International Clinical Trial Collaborations

Institution Project Funding
Macquarie University Determining the impact of a new primary care model for low back pain: A cluster randomised trial $2.1 million
University of Melbourne The C*STEROID Trial: An international, randomised placebo-controlled trial to determine the effect of antenatal corticosteroids on newborn health when given prior to planned caesarean section birth from 35+0 to 39+6 weeks of pregnancy $2.2 million
University of Sydney RADAR: A randomised PET-adapted study of bleomycin-free treatment of early stage Hodgkin lymphoma $1.4 million

2020 Neurofibromatosis Research grant opportunity

Institution Project Funding
Murdoch Children’s Research Institute Malignant Peripheral Nerve Sheath Tumour Genomics in Neurofibromatosis 1 (MaGeN) $1.6 million
The University of Newcastle The Neurofibromatosis type 1 (NF1) Cutaneous Neurofibroma Consortium: Identifying Genetic modifiers of disease burden to inform treatment pathways $1.6 million
Monash University Defining NF1 clinical variation at the microscale to discover new therapeutic targets $818,000
Murdoch Children’s Research Institute A randomised control trial of remote microphone listening devices in children with neurofibromatosis type 1 and central auditory deficits $599,000

2020 Traumatic Brain Injury Mission

Institution Project Funding
Curtin University An informatics approach to predict outcomes and monitor intervention efficacy following moderate to severe traumatic brain injury $500,000
University of Sydney From injury to long-term physical activity for people living with traumatic brain injury $407,000
Monash University PRECISION-TBI – Promoting evidence-based, data driven care for critically ill moderate-to-severe TBI patients $499,000
Monash University The Australian Traumatic Brain Injury National Data (ATBIND) Project $366,000
Monash University Exercise therapy for mild traumatic brain injury (mTBI) and persistent post-concussion symptoms (PPCS) across the lifespan $500,000
University of Tasmania Transforming Awareness, Literacy & Knowledge of Traumatic Brain Injury (TALK-TBI) $1 million

Suspension of mutual obligation requirements for job seekers and participants in Queensland

The Morrison Government has suspended mutual obligation requirements for employment services participants in Queensland in the Local Government Areas of Townsville, Palm Island, Brisbane, Gold Coast, Ipswich, Lockyer Valley, Logan, Moreton Bay, Noosa, Redland, Scenic Rim, Somerset and Sunshine Coast.
The temporary suspension of mutual obligation requirements for employment services participants in these areas will be in place from today, Tuesday 29 June until Tuesday 6 July 2021 inclusive.
No employment services participant in the affected Local Government Areas will face payment suspension or financial penalties for failing to meet their mutual obligation requirements, such as not being able to attend appointments or activities, or not meeting their Job Search requirement if it is due while mutual obligation requirements are suspended.
Where it is safe to do so in line with health advice, employment services participants can engage with their employment services provider.
These arrangements will apply to job seekers in jobactive, Online Employment Services, Disability Employment Services, and participants in ParentsNext and the Community Development Program.
More information about mutual obligation requirements for jobactive, Online Employment Services, and participants of ParentsNext can be found at www.dese.gov.au/covid-19/job-seekers

Enhanced support for NDIS participants in New South Wales

The Morrison Government is committed to ensuring the safety of National Disability Insurance Scheme (NDIS) participants during the current COVID-19 outbreak in New South Wales (NSW).
More than 61,000 NDIS participants across Australia have now received at least one dose of the vaccine. We continue to see strong growth in numbers across all states and territories.
Minister for the National Disability Insurance Scheme Senator the Hon Linda Reynolds CSC, said for NDIS participants within Phase 1a in NSW, provider-led vaccination hubs are operating in North Parramatta, Newcastle, Islington and Baulkham Hills.
“In a COVID-19 outbreak where there is ongoing community transmission and extended lockdown periods, it’s been critical that we’ve been able to quickly introduce or reinstate temporary measures to support people in those areas,” Minister Reynolds said.
“The Commonwealth is now also prioritising efforts in NSW to provide in-reach for eligible residential disability accommodation located in the declared COVID-19 hotspots, Greater Sydney, the Blue Mountains, the Central Coast and Wollongong.
“I strongly encourage people with disability, their care and support workers and their carers to get vaccinated through the five streams now available to increase protection for themselves and their community.
“I’d like to thank disability service providers, support workers and carers of people with disability for their work in support of the vaccine rollout to this vulnerable group.”
In addition to dedicated disability vaccination hubs, the following measures are in place:

  • All NDIS participants aged 16 years and over and carers aged 16 years and over of NDIS participants of any age are eligible to receive the vaccine.
  • Disability workers can access the vaccine at Commonwealth SONIC vaccine clinics in Campbelltown, Sydney CBD, Macquarie and Blacktown.
  • A national support payment of $150 per participant for disability providers to assist NDIS supported independent living participants eligible within Phase 1a to attend offsite locations, including Commonwealth hubs, state clinics and GPs.
  • The National Disability Insurance Agency (NDIA) reinstated a measure, effective from 26 June, to enable NDIS providers in declared COVID-19 hotspot areas of NSW to directly claim the cost of PPE for disability support workers in light of the current COVID-19 outbreak.
  • The NDIA also reinstated and expanded a measure to allow eligible registered NDIS providers Australia-wide to seek participant approval to access NDIS participant plan funds to claim costs for PPE used for supports delivered in person by a worker due to higher than normal PPE requirements.
  • The NDIA has continued to make available additional temporary support items (for deep cleaning, higher intensity staffing requirements, professional laundering) to assist participants living in supported independent living arrangements where additional supports are required due to a COVID-19 outbreak.
  • The NDIA maintains a Clinical First Responder capability that, as a last resort, can provide emergency intervention, clinical support and infection control should there be a COVID-19 outbreak or positive infection in a NDIS residential disability accommodation setting.

For more information on where participants and carers can receive their vaccine, visit health.gov.au/covid19-vaccines

The Academy continues in COVID-safe bubble

The CMAA Academy of Country Music staff members and Calrossy Anglican School are working together to ensure The Academy continues to run safely under new COVID-19 regulations.

The Academy is providing an intensive educational course to students and their parents from NSW, South Australia, Victoria and Queensland.
Staff members met with Calrossy executive on Saturday, June 26, following further COVID-19 restrictions coming into force in NSW to ensure all regulations were followed and the community was kept safe. The Academy staff members and students have created a ‘bubble’ at Calrossy where they are not in contact with the general public and have all returned negative COVID-19 tests in the past week and have isolated since being tested. This bubble will be kept in place until The Academy concludes on Saturday, July 2.
“We are so grateful we can still come together for the 2021 Junior Academy course here in Tamworth,” Academy director Lyn Bowtell said.
“I am so proud of the way everyone has worked together to ensure our music education and business course can continue to run in these difficult times. This truly shows the resilience and dedication of our staff members, students and parents who have worked with us to ensure everyone’s safety.”
As the course is an educational institution running in a school, participants are able to sing and gather while following all NSW Government regulations.
However, these changes have meant special guests including The Bushwackers front man Dobe Newton, producer Simon Johnson, singer-songwriters Aleyce Simmonds and Catherine Britt, musician and artist Mickey Pye have presented their sessions to the parents and students via Zoom videoconferencing. Being the innovative creatives that musicians and music industry personnel are, using this technology and adapting to it has meant that the course participants still get the full gamut of experiences that The Academy offers.
The graduation concert will be closed to the public, but will be livestreamed via The Academy Facebook page at 8pm on Thursday, July 1.
Being able to come together as a safe and isolated group has also meant the world to staff members, students and parents as many have been unable to gather in person for nearly 18 months.
The last time The Academy ran in person was January 2020 with the senior course, and has since run as Academy X, an online version and these will continue to run as specialty courses delivered via Zoom.
The Academy personnel also thanked Calrossy Anglican School executives for working with them to run another successful Academy of Country Music.

Emergency leave extension for aged care residents

The Morrison Government is extending emergency leave arrangements for people living permanently in residential aged care who want to temporarily relocate with family to reduce their risk of contracting COVID-19.
The 12-month extension means the emergency leave provisions are now in place until 30 June 2022.
Minister for Senior Australians and Aged Care Services, Richard Colbeck, said the extension allows aged care residents to continue to take emergency leave during unpredictable COVID-19 outbreaks, rather than using their limited social leave entitlements.
“We want to provide certainty and reassurance to residents who wish to temporarily relocate and stay with family at times when COVID-19 is a risk in their aged care residence,” Minister Colbeck said.
“The Morrison Government is providing two tiers of support available through the Commonwealth Home Support Programme (CHSP) for people taking emergency leave.
“This includes personal care and nursing services, as well as entry level supports, such as meals and transport.”
Emergency leave provisions were introduced in May 2020, giving permanent aged care residents the option to take emergency leave during a declared emergency.
The entitlement was initially in place from 1 April 2020 to 30 September 2020 and has already been extended once to 30 June 2021.
Permanent aged care residents are usually entitled to up to 52 days of non-hospital related leave (social leave) within a financial year under the Aged Care Act 1997.
When residents take emergency leave they must continue to pay their basic daily fees, means tested care fees and daily accommodation fees, which is the same requirement when taking social leave.
During the leave period, the Australian Government continues to pay residential care subsidies, ensuring providers are not disadvantaged when residents take emergency leave.
More information on emergency leave and CHSP supports is available on the Department of Health website.

National Cabinet Statement

The National Cabinet met today to discuss Australia’s COVID-19 response, recent outbreaks of COVID-19 and the Australian COVID-19 Vaccine Strategy.
National Cabinet continues to work together to address issues and find solutions for the health and economic consequences of COVID-19.
Across Australia a number of new community outbreaks have appeared in Greater Sydney, Brisbane, the Sunshine Coast, the Darwin region and the Perth-Peel region. Concerningly a number of these outbreaks are linked to the delta variant which has significantly higher transmissibility.
Health measures put in place by National Cabinet throughout the pandemic have been effective in bringing outbreaks under control and reducing the severity of the health impacts. While there are now over 270 active cases in Australia (166 in NSW, 45 in Vic, 40 in Qld, 9 in SA, 8 in NT, 3 in WA), there are only 2 cases in ICU and no Australian is on a ventilator.
Since the beginning of the pandemic there have been 30,528 confirmed cases in Australia and, sadly, 910 people have died. More than 20.4 million tests have been undertaken in Australia. Testing has increased nationally over recent days with 628,000 tests reported in the past 7 days.
Globally there have been over 181 million cases and sadly over 3.9 million deaths, with 318,555 new cases and 6,422 deaths reported in the last 24 hours. The COVID-19 pandemic continues to surge in many countries around the world.
Australia’s COVID-19 vaccine rollout continues to expand. To date 7,374,666 doses of COVID-19 vaccines have been administered in Australia, including 48,346 doses in the previous 24 hours. In the previous 7 days, 783,925 vaccines have been administered in Australia. To date 28.6 per cent of the Australian population aged 16 and over have now had at least a first dose of a COVID-19 vaccine, including over 68.1 per cent of over 70 year olds.
COVID-19 vaccinations are working to reduce transmission. National Cabinet noted that in a recent exposure event in NSW, of the 30 people that were at the event, 24 unvaccinated people have now tested positive for COVID, but six vaccinated people who attended the event have not been infected at this stage with the COVID-19 virus.
National Cabinet agreed on the imperative to work together to administer COVID-19 vaccinations to Australians as quickly as possible.
Chief Medical Officer Professor Paul Kelly provided an update on current outbreaks of COVID-19 in a number of locations and of both the Alpha and Delta variants.
National Cabinet noted the importance of national coordination and that the Commonwealth Department of Health National Incident Centre will continue to coordinate action across Australia.
Lieutenant General John Frewen, Coordinator General of Operation COVID Shield, provided a detailed briefing on the vaccination program.
Lt General Frewen reaffirmed that all states and territories are provided COVID-19 vaccinations on a proportional population basis, as agreed by National Cabinet. To date over 10.8 million doses have been allocated to states and territories, general practices (GPs), Aboriginal Community Controlled Health Organisations (ACCHOs) and community pharmacies. Lt General Frewen noted that there are more than 2.6 million doses of AstraZeneca currently available to be administered. National Cabinet encouraged the 2.3 million Australians aged 60 years and over who have not yet been vaccinated to come forward and be vaccinated now.
Around 221,000 second doses of AstraZeneca were administered last week, the week after the latest ATAGI advice.
An additional 236 GPs have been brought online to administer COVID-19 vaccines, bringing the total number of GPs administering the vaccine to 5,085 across Australia. Community pharmacists are also being bought online to support the rollout in regional Australia.
National Cabinet noted that Lt General Frewen will commence a wargaming process with states and territories to ensure that the distribution channels and access points are sufficient once the supply of vaccines further increases.
National Cabinet agreed to meet next on Friday 2 July 2021.
Mandatory Vaccinations for Aged Care Workers
The National Cabinet agreed to mandate that at least the first dose of COVID-19 vaccine be administered by mid-September 2021 for all residential aged care workforce.
The National Cabinet agreed that COVID-19 vaccinations are to be mandated for residential aged care workers as a condition of working in an aged care facility through shared state, territory and Commonwealth authorities and compliance measures.
This is the third time AHPPC has considered this matter. They will continue to look at the issue to ensure we do not encounter any unintended consequences as an outcome of this decision.
The Commonwealth will support this decision though an employee vaccination support grant.
Residential Aged Care COVID-19 Employee Vaccination Support Grant
Residential aged care workers will be supported to be vaccinated through an $11 million program to enable them to attend off-site vaccination centres and GPs.
Under the grant, Residential Aged Care Facilities (RACFs) will be paid for the following three categories of eligible expenditure:

  • Casual staff going off-site for vaccination – a flat fee of $80 payable per staff member, per dose;
  • Paid leave for casual staff who become unwell after vaccination and do not have other leave entitlements – one day’s paid leave (at a rate of $185) for up to a quarter of the provider’s total number of casual staff; and
  • Facilitation of off-site vaccination for employees – up to $500 per site in flexible vaccination facilitation costs per site, which may be used for activities like: transport services, arranging groups of staff to be vaccinated and or any other reasonable expenses that incentivise staff to get vaccinated.

Quarantine
National Cabinet agreed to changes to Australia’s quarantine arrangements based on AHPPC advice:

  1. National Cabinet endorsed the AHPPC advice: Minimising the risk of transmission from high risk international travellers in managed quarantine facilities
    The AHPPC recommends accommodating international quarantine residents, or other high infectious risk quarantine residents, separately from other lower risk residents. This may involve designating different facilities or zoning through allocating separate areas in a facility (i.e. designated floors for international or other high risk travellers). In the event that international quarantine residents share a facility, zoning may be implemented by putting groups in cohorts according to level of risk and ensuring that staff do not work across zones.
  2. National Cabinet endorsed the AHPPC advice: Testing travellers once they leave managed quarantine, and requested that AHPPC work on implementation to mandate post quarantine testing and specifications for this.

    AHPPC reinforced advice that all travellers leaving managed quarantine must get tested and isolate until they receive a negative test result if they develop symptoms at any time in the 14 days after leaving quarantine.
    AHPPC agreed that all international travellers should get tested at days 16 or 17 following quarantine, if there have been potential exposure sources within the quarantine facility, regardless of whether they have symptoms. Options are being explored to support post-quarantine testing at the national level. AHPPC will continue to explore the management of persons post-quarantine to reduce the risk to the community whilst testing is being undertaken.
  3. National Cabinet endorsed the AHPPC advice: Vaccinating and testing quarantine workers to require vaccinations and testing for quarantine workers including those involved in transportation.
    Protecting quarantine workers is an essential part of reducing the risk of transmission and incursion into the community. The primary mechanisms through which this can be achieved is vaccinating all quarantine workers and undertaking regular routine testing of workers to identify transmission events should they occur.
    Vaccinations: All quarantine workers and their household contacts are eligible for COVID-19 vaccination.
    All quarantine workers should be strongly encouraged to undergo vaccination, and jurisdictions may implement requirements for quarantine workers to receive vaccinations. This includes those directly employed in quarantine facilities under Commonwealth, state or private arrangements. Importantly, this also includes anyone who works in a red zone.
    Given recent incursions, Delta variants and the current epidemiology of clusters occurring around Australia, the AHPPC recommends mandatory vaccination for all quarantine workers.
    Testing: In November 2020, the AHPPC recommended regular testing of quarantine workers. In response to the increasing risk posed by Variants of Concern, since February 2021, daily testing of quarantine workers has been implemented nationally. However, to date this has been limited to those directly involved in managed quarantine programs.
    In response to lessons learned from recent transmission events, current epidemiology and discussion through the Continuous Improvement Framework, the AHPPC recommends extending this requirement to all workers directly and indirectly involved in managed quarantine. This includes workers involved in transport of quarantined individuals.
  4. National Cabinet agreed that travellers who have been through 14 days hotel quarantine in one jurisdiction will be able to enter another jurisdiction without having to go through another 14 days quarantine. These travellers will still be required to take a post quarantine COVID-19 test at day 16 or 17.

National Cabinet further reaffirmed that managed quarantine for international arrivals continues to play a vital role in Australia’s public health response to COVID-19. Through the Continuous Improvement Framework, the Australian Health Protection Principal Committee (AHPPC) regularly considers lessons learned in managed quarantine including the outcomes of evaluations, audits and reviews. This supports a process of continuous quality improvement in line with the National Principles for Managed Quarantine.
Indemnity arrangements for COVID-19 vaccinations
National Cabinet noted that the Commonwealth will establish a COVID-19 professional indemnity scheme to provide additional certainty to healthcare practitioners who are providing advice to people in relation to COVID-19 vaccination. The scheme covers COVID-19 vaccines approved by the TGA and approved for use in the vaccine program.
National Cabinet noted that GPs can continue to administer AstraZeneca to Australians under 60 years of age with informed consent and that this measure will provide confidence to medical practitioners to administer both AstraZeneca and Pfizer vaccines to Australians.
Aviation, interstate freight transport and mining (FIFO) workers
National Cabinet agreed to seek advice from AHPPC on COVID-19 vaccinations for aviation, interstate freight transport and mining (FIFO) workers.

New CEO to lead health and welfare data agency

The Australian Government welcomes the appointment of Mr Robert Heferen to lead the Australian Institute of Health and Welfare (AIHW).
With more than 30 years’ experience in the public service, Mr Heferen will take on the role of Chief Executive Officer from early July, 2021.
Mr Heferen brings a deep knowledge of policy and programs as a former Deputy Secretary in the Department of Education, Skills and Employment, the Department of the Environment and Energy, and the Department of Industry, Innovation and Science. He has also held leadership roles at the Australian Tax Office, Treasury and the Department of Families, Housing, Community Services and Indigenous Affairs.
Mr Heferen’s extensive experience will be vital to the AIHW, who continue to play a critical role in health and welfare policy and program development across Australia. The independent agency is internationally recognised for its expertise and proven track record in producing information and statistics which underpin our health and welfare systems.
The Government extends its thanks to outgoing CEO, Mr Barry Sandison, who oversaw significant reforms at the agency and has positioned AIHW successfully for the future.
Mr Sandison’s contributions have transformed the agency, expanding the suite of products and services and overseeing significant improvements in the way data is presented, making it more accessible and easier to understand.
The Government congratulates Mr Heferen on his appointment, who we expect will continue this program of reform and improvement, ensuring we have access to authoritative information and statistics to underpin our world-leading health and welfare systems.

Boost to rural health training

The Australian Government will extend one of the nation’s premier rural health workforce initiatives, following an evaluation of the programme highlighted its effectiveness in addressing workforce shortages.
Regional Health Minister, Mark Coulton, said Rural Health Multidisciplinary Training Program will continue to provide more than $200 million per year over three years to fund a network of rural clinical schools, university departments of rural health, and regional training hubs across rural and remote Australia.
“Extending the Rural Health Multidisciplinary Training (RHMT) Program reaffirms the Government’s commitment to addressing health workforce shortages in rural areas.
“The RHMT is one of our most effective rural workforce initiatives and I’m pleased to see it continue with the funding and settings it needs to deliver better outcomes for rural communities,” Mr Coulton said.
“The evaluation demonstrates that universities continue to provide health students with quality rural clinical training experiences and that the presence of universities in regional, rural, and remote communities has social and economic benefits to these communities and their health services.”
The review’s recommendations aim to build on the success of the 20-year-old program. These recommendations recognise the teaching innovations and maturity of the program, while allowing for some areas of reform.
The reforms, to be phased in from 1 January 2022, will focus on key program outcomes such as student selection and quality placements, strengthening research networks, and responding to community and workforce need.
“The RHMT program has been with us for two decades,” the Minister for Regional Health, Mark Coulton, said. “These reforms will open a new chapter in its success story.”
“They will further enhance its key role in increasing the number of qualified health professionals in rural, regional and remote Australia, providing high quality training and helping to bridge the city-country divide in access to health services.”
“We will work with the stakeholders to further strengthen and develop rural training opportunities and to keep building on this program for the future.”
The RHMT program is one of several Commonwealth rural health workforce programs supporting more health professionals to work in the bush.
It funds a network of rural clinical schools, university departments of rural health, dental faculties offering extended rural placements, and the Northern Territory Medical Program. The RHMT program also supports 26 regional training hubs.
Twenty-one universities currently participate in the program and the Australian Government’s annual investment is more than $200 million.
A closed non‑competitive grant opportunity will be undertaken to facilitate this three-year extension.

$10.1 million to reduce number of younger people in residential aged care

The Australian Government continues to deliver on its commitment to reduce the number of younger people living in residential aged care.
Minister for Senior Australians and Aged Care Services, Richard Colbeck and Minister for Government Services, Linda Reynolds CSC said the Government is investing $10.1 million in a national network to help younger people and their families find age-appropriate accommodation and additional support.
“The aged care system was designed to best support the needs of senior Australians, not younger people,” Minister Colbeck said.
“We remain deeply determined to ensure younger people in need of care can find the support outside of the aged care environment.”
As part of the 2020–21 Budget, the Morrison Government committed to funding a national network of up to 40 Younger People in Residential Aged Care System Coordinators.
Minister Reynolds said thanks to a recent competitive grant opportunity Ability First Australia will bring the knowledge, skills and expertise to this important reform.
“Ability First will work with younger people and their families to help them access disability services, health services, housing and social supports,” Minister Reynolds said.
“This will ensure younger people who want to live on their own terms and with independence in the community will have the support they need to live their best life.”
Ability First Australia is one of Australia’s largest not-for-profit strategic alliances, with 14 member organisations working across all states and territories.
Its members have expertise in supporting and advocating for people with disability.
In its initial response to the Royal Commission Interim Report, the Morrison Government announced strengthened Younger People in Residential Aged Care targets and an intention to develop a strategy to meet those targets.
Apart from exceptional circumstances, the Government is committed to ensuring:

  • Nobody under the age of 65 enters residential aged care by the end of 2022;
  • No one under the age of 45 is living in residential aged care by the end of 2022; and
  • No people under the age of 65 are living in residential aged care by the end of 2025.

Minister Colbeck said the latest steps illustrated the Government’s ongoing commitment to providing better options for what can be a deeply emotional and complex issue.
“We know the impact this can have on individuals and their families who have too often been left with no other choice,” he said.
Minister Reynolds said the Government is committed to ensuring the individual needs of younger people are met.
“This is an issue very close to my heart. The first Senate Inquiry I championed was into this issue as I firmly believe that no younger Australian with a disability should be forced to live in aged care because there is no alternative,” Minister Reynolds said.
More information about the Younger People in Residential Aged Care Strategy 2020–2025 can be found on the Department of Social Services website.

Hockeyroos at home at upgraded recovery centre

The opening of a new state-of-the-art change room and recovery facility has given Australia’s women’s hockey squad, the Hockeyroos, a huge boost ahead of the postponed Tokyo Olympic Games.
The “Roos’ Retreat” was officially opened by the Federal Member for Swan the Hon Steve Irons at Perth Hockey Stadium today on behalf of the Minister for Sport Richard Colbeck.
The $600,000 upgrade to the hockey facilities was funded as part of the Morrison Government’s $11.5 million commitment to high performance sport infrastructure.
The upgraded Perth Hockey Stadium at Curtin University now includes equal change rooms for the Australian men’s and women’s hockey squads as well as recovery areas with an ice-bath and spa area and a gymnasium.
It comes as The Hockeyroos are set to challenge for a podium finish and a fourth Olympic gold medal at next month’s Games.
Minister Colbeck and Mr Irons said the investment was key to support one of Australia’s best-loved and most successful teams.
“The Hockeyroos carry the status as one of Australia’s iconic sporting teams and they deserve world-class facilities, which the Morrison Government is proud to support,” Minister Colbeck said.
“This is more than an investment in bricks and mortar.
“It also signals confidence in the sporting champions who represent and continually inspire our nation.
“Our female athletes and teams are incredibly important role models, inspiring and empowering more young girls to see the benefits of sport participation.
The Australian Government, through the Australian Institute of Sport, has increased funding to the Hockeyroos for their Tokyo Olympic campaign, delivering more than $12 million since 2016 to support the national squad.
Mr Irons said the investment would cement Perth’s status as Australia’s home of high performance hockey.
“Perth has been home to Australia’s national hockey squads since 1984, which has attracted so many athletes to relocate here and become part of the community,” Mr Irons said.
“This stadium is also home to Hockey Western Australia and caters for developing players as well as national team members.
“These facilities will be a beacon for aspiring hockey players across the country who have dreams of representing Australia at the highest level.”